Seres Therapeutics, Inc. (MCRB)
NASDAQ: MCRB · Real-Time Price · USD
7.06
+0.09 (1.36%)
At close: May 9, 2025, 4:00 PM
7.38
+0.33 (4.61%)
After-hours: May 9, 2025, 7:49 PM EDT

Seres Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Cash & Equivalents
58.8530.79127.97163.03180116.05
Upgrade
Short-Term Investments
---18.31110.7137.57
Upgrade
Cash & Short-Term Investments
58.8530.79127.97181.34290.71253.62
Upgrade
Cash Growth
-47.07%-75.94%-29.43%-37.62%14.62%167.48%
Upgrade
Receivables
2.762.07---9.39
Upgrade
Prepaid Expenses
4.475.818.0513.4212.925.77
Upgrade
Other Current Assets
--39.4---
Upgrade
Total Current Assets
66.0838.67175.41194.76303.63268.78
Upgrade
Property, Plant & Equipment
89.4192.44108.03133.9736.1522.94
Upgrade
Long-Term Investments
----0.549.83
Upgrade
Other Long-Term Assets
8.78.775.1620.0514.591.4
Upgrade
Total Assets
164.18139.81358.6348.78354.86342.94
Upgrade
Accounts Payable
2.174.083.6417.4413.744.02
Upgrade
Accrued Expenses
6.2210.7222.5125.072414.23
Upgrade
Current Portion of Long-Term Debt
---0.46-0.45
Upgrade
Current Portion of Leases
9.058.675.593.66.615.12
Upgrade
Current Unearned Revenue
---4.2616.8222.6
Upgrade
Other Current Liabilities
13.8917.7566.9234.7721.1-
Upgrade
Total Current Liabilities
31.3241.2298.6685.682.2646.42
Upgrade
Long-Term Debt
--101.5450.5924.6424.64
Upgrade
Long-Term Leases
80.582.9791.65107.9417.9610.56
Upgrade
Long-Term Unearned Revenue
---92.438785.57
Upgrade
Other Long-Term Liabilities
1.91.84111.61.4411.51
Upgrade
Total Liabilities
113.72126.03403.46338223.35168.19
Upgrade
Common Stock
0.010.170.140.130.090.09
Upgrade
Additional Paid-In Capital
995.87991.71933.24875.18745.83723.48
Upgrade
Retained Earnings
-945.42-978.1-978.24-864.51-614.35-548.78
Upgrade
Comprehensive Income & Other
----0.01-0.06-0.05
Upgrade
Total Common Equity
50.4713.78-44.8610.78131.51174.75
Upgrade
Shareholders' Equity
50.4713.78-44.8610.78131.51174.75
Upgrade
Total Liabilities & Equity
164.18139.81358.6348.78354.86342.94
Upgrade
Total Debt
89.5591.64198.78162.5949.2140.77
Upgrade
Net Cash (Debt)
-30.7-60.85-70.8218.75241.5212.85
Upgrade
Net Cash Growth
----92.23%13.46%325.39%
Upgrade
Net Cash Per Share
-0.01-7.83-11.073.4752.6753.35
Upgrade
Filing Date Shares Outstanding
8.738.727.556.34.64.58
Upgrade
Total Common Shares Outstanding
8.738.656.756.264.594.57
Upgrade
Working Capital
34.76-2.5576.75109.17221.37222.36
Upgrade
Book Value Per Share
5.781.59-6.641.7228.6238.21
Upgrade
Tangible Book Value
50.4713.78-44.8610.78131.51174.75
Upgrade
Tangible Book Value Per Share
5.781.59-6.641.7228.6238.21
Upgrade
Machinery
-32.9233.0931.5823.6119.89
Upgrade
Construction In Progress
-0.861.113.971.670.35
Upgrade
Leasehold Improvements
-30.9532.4932.4732.9327.98
Upgrade
Updated Mar 13, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q